Jillian B. Thomsen

2018

In 2018, Jillian B. Thomsen earned a total compensation of $6.2M as Senior Vice President Finance and Chief Accounting Officer at Nektar Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$424,100
Option Awards$899,490
Salary$435,000
Stock Awards$4,461,657
Other$13,347
Total$6,233,595

Thomsen received $4.5M in stock awards, accounting for 72% of the total pay in 2018.

Thomsen also received $424.1K in non-equity incentive plan, $899.5K in option awards, $435K in salary and $13.3K in other compensation.

Rankings

In 2018, Jillian B. Thomsen's compensation ranked 1,485th out of 14,244 executives tracked by ExecPay. In other words, Thomsen earned more than 89.6% of executives.

ClassificationRankingPercentile
All
1,485
out of 14,244
90th
Division
Manufacturing
518
out of 5,765
91st
Major group
Chemicals And Allied Products
165
out of 2,128
92nd
Industry group
Drugs
130
out of 1,817
93rd
Industry
Pharmaceutical Preparations
96
out of 1,391
93rd
Source: SEC filing on April 30, 2019.

Thomsen's colleagues

We found four more compensation records of executives who worked with Jillian B. Thomsen at Nektar Therapeutics in 2018.

2018

Howard Robin

Nektar Therapeutics

Chief Executive Officer

2018

Gil Labrucherie

Nektar Therapeutics

Chief Financial Officer

2018

Stephen Doberstein

Nektar Therapeutics

Chief Research and Development Officer

2018

Maninder Hora

Nektar Therapeutics

Senior Vice President Pharmaceutical Development and Chief Technical Operations Officer

News

You may also like